admin 
Gabriel Paijo 
Hendra Lukman 
George Ongkojoyo 
Billy Candra Kathryn Taylor PhD Receives CureSearch Young Investigator Award to Pioneer Neuromodulatory Treatments for Pediatric Brain Cancer
Memorial Sloan Kettering Cancer Center researcher Kathryn Taylor, PhD, has been named the latest recipient...
Immunotherapy Revolutionizes Kidney Cancer Treatment, Offering Renewed Hope and Extended Survival.
A kidney cancer diagnosis, historically a harbinger of profound uncertainty and fear, is increasingly met...
Unmasking the Dual Nature of Regulatory T Cells: A Breakthrough in Colorectal Cancer Immunotherapy
In a significant advance for cancer research, scientists at the Sloan Kettering Institute (SKI) at...
A “mirror” molecule can starve cancer cells without harming healthy cells
Budi Oetomo Narendra The conventional arsenal against cancer, including chemotherapy and radiation, primarily functions by attacking rapidly dividing...
Severe Respiratory Infections and Lung Cancer Risk: New UVA Research Links COVID-19 and Influenza to Long-Term Pulmonary Tumor Development
Suherman Candra Maholtra New research from the University of Virginia (UVA) Health’s Beirne B. Carter Center for Immunology...
Flinders University Researchers Uncover Critical Link Between Dual Bowel Polyps and Significantly Elevated Cancer Risk
Gilang Cahya Researchers from Flinders University and Flinders Medical Centre have identified a crucial and previously underestimated...
Kobe University Researchers Develop Groundbreaking AI for Early Acromegaly Detection Using Hand Images, Prioritizing Patient Privacy
Lina carolina Researchers at Kobe University have unveiled a revolutionary artificial intelligence system capable of identifying the...
BioNTech Founders Ugur Sahin and Özlem Türeci to Depart, Launching New mRNA Discovery Venture
Ugur Sahin and Özlem Türeci, the visionary co-founders who meticulously steered BioNTech from a nascent...
Scientists Develop Novel Antibody Targeting SFRP2 to Combat Triple Negative Breast Cancer and Overcome Treatment Resistance
Researchers at the MUSC Hollings Cancer Center have announced a significant breakthrough in the treatment...
Combination of Niraparib and Abiraterone Significantly Delays Progression in Advanced Prostate Cancer Patients with Specific Genetic Mutations.
A landmark international study spearheaded by researchers at University College London (UCL) has unveiled a...
